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Calcium (Ca2+) is an essential signal transduction element involved in the regulation of several cellular activities and
it is required at various key stages of the cell cycle. Intracellular Ca2+ is crucial for the orderly cell cycle progression
and plays a vital role in the regulation of cell proliferation. Recently, it was demonstrated by in vitro and in vivo
studies that nucleoplasmic Ca2+ regulates cell growth. Even though the mechanism by which nuclear Ca2+
regulates cell proliferation is not completely understood, there are reports demonstrating that activation of tyrosine
kinase receptors (RTKs) leads to translocation of RTKs to the nucleus to generate localized nuclear Ca2+ signaling
which are believed to modulate cell proliferation. Moreover, nuclear Ca2+ regulates the expression of genes
involved in cell growth. This review will describe the nuclear Ca2+ signaling machinery and its role in cell
proliferation. Additionally, the potential role of nuclear Ca2+ as a target in cancer therapy will be discussed.
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Intracellular calcium (Ca2+) participates as a second
messenger in several signaling pathways coordinating
key events in a variety of cellular functions [1]. Ca2+
Signals are generally initiated by the binding of a hor-
mone or growth factor to a transmembrane receptor,
most commonly G protein coupled receptor (GPR) or
tyrosine kinase receptor (RTK). The activation of such
receptors recruits several second messengers, including
phospholipase C (PLC) that, once activated, cleaves
phosphatidylinositol 4,5-biphosphate (PIP2) producing
diacylglycerol and inositol-1,4,5-trisphosphate (InsP3).
InsP3 then binds to the InsP3 receptor (InsP3R), activa-
ting its channel to release Ca2+ from the endoplasmic
reticulum. Once in the cytosol, Ca2+ can participate in
several intracellular cascades and activate another class of
Ca2+ channels, the ryanodine receptor (RyR), triggering a
process denoted Ca2+-induced Ca2+ release [1]. The type
II and III RyR are also sensitive to cyclic ADP-ribose
(cADPR) [2,3], a process first demonstrated in sea urchin* Correspondence: leitemd@dedalus.lcc.ufmg.br
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reproduction in any medium, provided the oreggs [4], but now known to mobilize Ca2+ in a wide range
of mammalian cell types [3,5-8]. Members of a third fa-
mily of intracellular Ca2+ channels, the two pore channels
(TPCs), are activated by nicotinic acid adenine dinucleo-
tide phosphate (NAAD) which promotes release of Ca2+
from acidic organelles [9,10]. Like cADPR, NAADP was
discovered in sea urchin eggs [11] and has now been
found to induce Ca2+ signaling in mammalian cells as well
[9,10]. Interactions among these different intracellular Ca2+
channels coordinate cellular responses mediated by Ca2+,
both in health and disease. However little is known
regarding the interaction of intracellular Ca2+ channels in
the regulation of nuclear Ca2+ signaling.
One way by which intracellular Ca2+ regulates multiple
cell functions is through spatial segregation of Ca2+ sig-
naling. Indeed, subcellular increases in Ca2+ modulate
not only physiological but also pathological events. For
example, the physiological secretion of zymogen
granules in pancreatic acinar cells is triggered by a
localized sub-apical Ca2+ increase that does not spread
throughout the entire cell [12]. In the other hand, the
hypertrophic response in cardiomyocytes depends
mostly on nuclear Ca2+ signals [13]. Additional examples
of cellular processes modulated by subcellular Ca2+ sig-
naling include the extension of growth cones in neuronall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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scription signatures [16], regulating development and
differentiation [17-20], among others [21].
Moreover, the presence of another regulatory nuclear
Ca2+ domain, denoted the nucleoplasmic reticulum
[22,23] was reported in a wide variety of cells, from
plants to animals (reviewed in [24]). The nucleoplasmic
reticulum, of which 2 classes have been described, is a
reticular membrane network of Ca2+ stores that is con-
tinuous with the endoplasmic reticulum and the nuclear
envelope. The type I contains invaginations of the inner
membrane of the nuclear envelope, and the type II
contains both the inner and outer nuclear envelope
membrane. These two classes of the nucleoplasmic
reticulum can coexist within the same nucleus (reviewed
in [24]), and their structure undergoes dynamic remod-
eling [25]. With the capacity to regulate Ca2+ signals in
subnuclear regions, the presence of such machinery
might provide a potential mechanism by which
nucleoplasmic Ca2+ could simultaneously regulate many
independent processes in the nucleus.
Although it is well known that nuclear Ca2+ has bio-
logical effects that differ from those mediated by
increases in cytosolic Ca2+ [21], the mechanisms by
which Ca2+ is specifically increased in the nucleoplasm
are a topic of debate. It was initially proposed that nu-
clear Ca2+ signaling would occur by passive diffusion of
cytosolic Ca2+ across the nuclear envelope into the nu-
cleoplasm. However, as it will be discussed in more detail,
the nuclear interior has all the machinery required to pro-
duce localized Ca2+ signals, supporting the concept of the
nuclear compartment as an independent apparatus to trig-
ger Ca2+ signals. Moreover, the mechanisms and pathways
by which localized Ca2+ signals in the nucleus regulate cell
growth have only recently been investigated. The emer-
ging model (Figure 1) shows that upon growth factor
stimulation, RTKs translocate to the nucleus to induce hy-
drolysis of nuclear PIP2, generating InsP3 in the nucleo-
plasm, which leads to nuclear Ca2+ signals that can
control cell growth [26-28] (Figure 1). This review
highlights recent advances on nuclear Ca2+ signaling and
its role in cell proliferation.
Ca2+ signaling in the nucleus
The nucleus is separated from the cytosol by the nuclear
envelope, which is a specialized region of the endoplas-
mic reticulum, comprised of phospholipid bilayers [24].
However, the nuclear envelope contains pores that are
permeable to molecules up to 60 kDa in size [29]. In the
absence of a gating mechanism, a pore of this size would
allow rapid equilibration of Ca2+ between the nucleus
and cytosol. Indeed, under certain circumstances, free
diffusion of Ca2+ through the nuclear pore occurs [30].
For example, stimulation of basophilic leukemia cellswith antigen or photoreleased InsP3 triggered Ca
2+
waves that spread from the cytosol into the nucleus [31].
Similar observations have been made in hepatocytes
stimulated with vasopressin [32]. In contrast, several
reports have demonstrate the existence of a nuclear-
cytosolic Ca2+ gradient in a number of cell types [33,34],
indicating that the permeability of nuclear pores to this
ion can be regulated. However, the detection of such
gradient can be incorrectly inferred depending on the
technique used to measure intracellular Ca2+ in different
compartments. Some of the commonly used organic Ca2+
indicators can display uneven distribution in the in-
terior of the cells and can preferentially accumulate
in membrane compartments such as the ER and the
nucleoplasm. More importantly, the affinity of fluores-
cent probes for Ca2+ can vary depending on the
cellular environment (reviewed [35]). Although each
method for analyzing Ca2+ has certain drawbacks it is
now appreciated that Ca2+ signaling is regulated at
the subcellular level, and that this level of regulation
is necessary for Ca2+ to act as a second messenger
that regulates multiple cell functions simultaneously.
The nuclear envelope itself is a Ca2+ rich compart-
ment, accumulating Ca2+ via a Ca2+-ATPase pump
(SERCA) and a Na+/Ca2+-exchanger [36-38] and relea-
sing it via channels that are sensitive to InsP3 [37,39],
cADPR [39,40], and NAADP [41]. The Ca2+-ATPase
pump was shown to be present only in the outer mem-
brane of the nuclear envelop, while the Na+/Ca2+-ex-
changer, is expressed in the inner membrane [38,42].
Regarding the intracellular Ca2+ channels, the RyRs
appears to be present on both leaflets of the nuclear en-
velope [43]. Similarly, there are reports of InsP3Rs in the
inner and outer membrane [28,44,45]. In addition, it was
shown that ADP-ribosyl (CD38), an enzyme required for
generation of cADPR, is located on the inner membrane
of the nuclear envelope [40]. In Aplysia neurons,
depolarization is the signal that triggers the translocation
of CD38 to the nucleus [46]. Moreover, the nuclear en-
velope possess the tool kit necessary to produce InsP3,
including PIP2, and PLC [47], and this machinery may
be activated selectively through tyrosine kinase path-
way [48].
However, the nuclear envelope is not the only nuclear site
containing the Ca2+ signaling machinery. The nucleoplasmic
reticulum represents another specialized cellular compart-
ment involved in regulation in time and space of specific
intracellular Ca2+ signaling events. For instance, both the
InsP3R and the RyR are found in the nucleoplasmic
reticulum [22,23]. Importantly, the InsP3-Kinase (IP3KB),
the isoform that inactivates the InsP3 by phosphorylating it,
was also reported to be located in the nucleoplasmic
reticulum, where it may function to terminate the InsP3
mediated Ca2+ signal [49]. In addition, SERCA was also
Figure 1 Schematic representation of events involved in nuclear Ca2+ release and cellular proliferation. Ca2+ signals can be activated in
the cells by the binding of a hormone or growth factor to a transmembrane receptor, most commonly a G protein coupled receptor or tyrosine
kinase receptor. Through complex signaling cascades and networks, these effectors lead to the activation of several second messengers. One of
the signaling pathways activated during cell proliferation is phospholipase C (PLC) that, once activated, cleaves phosphatidylinositol 4,5-
biphosphate (PIP2) producing diacylglycerol and inositol-1,4,5-trisphosphate (InsP3). InsP3 then binds to the InsP3 receptor (InsP3R), activating its
channel to release Ca2+. InsP3Rs can be found in the endoplasmic reticulum, in the nuclear envelope and in the nucleus along the nucleoplasmic
reticulum. InsP3R-induced Ca
2+ release specifically in the nucleus has been involved in the regulation of gene expression during different
pathophysiological conditions, as well as during cellular proliferation. The cartoon shows the type I nucleoplasmic reticulum structure, with an
invagination of the inner nuclear membrane alone. A Type II nucleoplasmic reticulum structure, with a double membrane walled invagination has
also been reported in many cell types, although it is not represented here. In the nucleus, these cellular invaginations can provide focal release of
Ca2+ that can bind directly to DNA structure or can modulate transcription factors involved in cell proliferation.
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nucleoplasmic reticulum [50]. Therefore, there are several
reports describing an active Ca2+ signaling regulatory do-
main deep in the nucleus, along the nucleoplasmic
reticulum, providing further spatial control of Ca2+ within
this cellular compartment [22,51,52].Corroborating these findings, there is a growing body of
data demonstrating that the nucleus has the capacity to in-
dependently generate Ca2+ signals. Several in vitro studies
have shown that InsP3 releases Ca
2+ directly from the nu-
clear envelop into the nucleus [33,39,44,53,54]. Accordingly,
it has been demonstrated in a liver cell line that extracellular
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dependent mechanism [55]. In cardiomyocytes, endothelin-
1 has also been shown to elicit a local nuclear envelope Ca2+
release via InsP3R that activates nuclear CaMKII triggering
HDAC5 phosphorylation and its nuclear export [56]. This
signaling pathway has been implicated in the regulation of
gene transcription in adult ventricular myocytes in response
to neurohumoral signals during hypertrophy. Similar to
InsP3, cADPR can also increase Ca
2+ in isolated cell nuclei
[33,39,40].
One of the proposed mechanism by which InsP3 generates
nuclear Ca2+ signaling is via translocation of activated RTKs
from the plasma membrane to the nuclear interior. For in-
stance, it was shown that IGF-1 and integrins caused PIP2
breakdown in the nucleus but not at the plasma membrane
[48]. Similarly, activation of the hepatocyte growth factor
(HGF) receptor c-Met in a liver cell line and insulin re-
ceptor in primary hepatocytes caused PIP2 breakdown in
the nucleus resulting in InsP3 formation that was followed
by nuclear Ca2+ signals [26,27] (Figure 1). The triggering
of this highly localized cascade was dependent on the
rapid translocation of the activated HGF receptor to the
nucleus, through a mechanism that depends on the adaptor
protein Gab-1 and importin-B [26]. Moreover, it also has
been hypothesized that relocation of MAP kinase to the nu-
cleus activates nuclear phospholipase C to generate InsP3
there [43].
Once in the nucleus, Ca2+ signals directly regulate sig-
naling pathways distinct from those mediated by cytosolic
Ca2+, for instance they stimulate the intranuclear activity
of PKC [22] and CaMK-IV [57]. Nuclear Ca2+ also plays a
significant role in regulating the transcription factor CRE-
binding protein and its coactivator, CREB-binding protein
(CBP) [58]. Transcriptional activation of Elk-1 by EGF was
also shown to depend on nuclear rather than cytosolic
Ca2+ [59]. On the other hand, nuclear Ca2+ can negatively
regulate the activity of transcription factors, such as TEAD
[60]. Moreover, nuclear Ca2+ has also been implicated in
modulating cardiac hypertrophy [13,51] and within the
nucleus Ca2+ was shown to bind to and directly regulate
DNA structure [61]. Another evidence of the role of nu-
clear Ca2+ signaling pathway came from studies showing
that in skeletal muscle cell, two-photon photorelease of
caged Ca2+ near the nucleoplasmic reticulum was found
to elicit a Ca2+-induced Ca2+ release event within the
nucleus [23]. More recently, it was demonstrated that
nuclear rather than cytosolic Ca2+ signals specifically
control the progression through early prophase, showing
that nucleoplasmic Ca2+ regulates cell proliferation [62].
Nuclear Ca2+ and cell proliferation
It has been long recognized that Ca2+ signals have an
important role throughout the mammalian cell cycle and
are especially important in early G1 and G1/S and G2/Mtransitions [63], with the first major Ca2+ transient oc-
curring just prior to entry into mitosis, and the second
one occurring during the metaphase-anaphase transition
[63,64]. Indeed, Ca2+ is the most prominent messenger
required through these cycle points [65,66] and down-
stream targets of Ca2+ have also been implicated in cell
cycle progression as well [67,68].
Heterologous expression of the Ca2+ binding protein
parvalbumin has been used to study the role of Ca2+
signals in the regulation of the cell cycle. This protein is
normally expressed in skeletal muscle and neurons [69],
and is known to buffer Ca2+ [70]. The first report using
parvalbumin as a molecular tool to buffer intracellular
Ca2+ and study cellular growth, showed that reducing
Ca2+ slowed progression through the cell cycle [68].
However, it is now known that the effects of Ca2+ on
proliferation correlate with the subcellular compartment
where Ca2+ is released. Using parvalbumin variants, se-
lectively targeted to distinct intracellular Ca2+ rich
compartments, it was found that buffering mitochon-
drial Ca2+ inhibits apoptosis and accelerates hepatocyte
proliferation [71]. In contrast, buffering cytosolic Ca2+
was shown to retard liver regeneration and progression
through the cell cycle after partial hepatectomy [72].
Since cytosolic Ca2+ can increase through a number of
mechanisms, it is believed that, in this compartment,
Ca2+ may have different effects on cell growth
[71,73,74]. On the other hand, it was shown that
nucleoplasmic rather than cytosolic Ca2+ is essential for
liver cell line proliferation, and is necessary in particular
for progression through early prophase [62]. It was also
found that liver tumors implanted in nude mice grew much
more slowly when expressing parvalbumin in their nuclei
compared to the cytosol [62]. Moreover, HGF and insulin,
two potent growth factors in liver, that induce cell
proliferation during liver regeneration, were shown to selec-
tively form InsP3 in the nucleus to initiate nuclear Ca
2+
signals [22,27] (Figure 1). Since the nucleoplasmic reticulum
is known to be abundant in many tumor cell types [24], one
would expect that the existence of these nuclear
invaginations could provide further specificity to cell
proliferation by allowing the focal delivery of Ca2+ to par-
ticular sites within the nucleus.
Although, the proteins that link nuclear Ca2+ signals to
cell proliferation have not been clearly identified, more re-
cent findings in liver tumor cells indicated the endopeptid-
ase legumain (LGMN) as a novel target of nuclear Ca2+
[75]. Using Rapid Subtraction Hybridization (RaSH) to sub-
tract genes in liver cells expressing the Ca2+ buffer protein
parvalbumin targeted to the nucleus, from genes in cells
expressing a mutated form of nuclear-targeted parvalbumin
which has one of the two Ca2+-binding sites inactivated.
The authors identified thirteen genes whose expression was
affected by a small alteration in nuclear Ca2+ concentration.
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was demonstrated to be regulated by nuclear Ca2+ signals at
the transcriptional level. LGMN was first recognized in
plants [76] and later in humans and mice [77]. It is present
in the tumor microenvironment where it is expressed by
macrophages and contributes to metastatic behavior by pro-
moting cell migration and tissue invasion. It is known that
increased expression of LGMN is associated with poor
tumor differentiation [78]. For instance, it was demonstrated
that LGMN co-localizes with integrins at the invading front
of tumors and expression of this enzyme was shown to be
associated with increased invasiveness [78,79]. So, it was
shown that when Ca2+ was buffered in the nucleus of
the cells, LGMN expression decreased, impairing cell
proliferation [75]. Additionally, this work also provided evi-
dence that nuclear Ca2+ signals regulate cell proliferation at
least in part through the modulation of gene expression
(Figure 1). Other targets for nuclear Ca2+ that are involved
in cell proliferation still remain to be described.
Altered nuclear morphology is a common feature of
many cancers [24] and it has been proposed that
information regarding the nucleoplasmic reticulum
invaginations could be used in combination with other
nuclear anomalies as markers of malignancy [80]. More
recently, it was also proposed that nuclear Ca2+
buffering could be used in conjunction with radiotherapy
as a therapeutic potential for the treatment of carcin-
oma. Ionizing radiation concomitant with nuclear Ca2+
buffering showed superior outcome, compared to irradi-
ation alone [81]. Corroborating previous findings, the
beneficial effect of nuclear Ca2+ buffering in the
proposed antitumor therapy was shown to be due to
changes caused in expression level of genes involved in
the regulation of cell proliferation [59]. Moreover, it
was also shown that buffering nuclear Ca2+ reduced
the rate of tumor cell proliferation, without affecting
cells from normal tissue [81], suggesting higher selec-
tivity of nuclear Ca2+ towards controlling cancer cell
growth. Further studies are required to determine the
mechanistic basis for the differential sensitivity of normal
versus cancer cell proliferation to changes in nuclear Ca2+.
Nonetheless, these findings suggest that buffering nuclear
Ca2+ could be one strategy employed to inhibit the growth
of tumors without affecting normal tissue, either alone or
in association therapy.
Conclusions
Ca2+ is important to several signaling pathways among vir-
tually every cell type. The central mechanism by which Ca2+
regulates protein functions depends on how and where it is
released into the cell. The role of nuclear Ca2+ in cell
proliferation was demonstrated in vitro by showing that nu-
clear Ca2+ buffering reduced proliferation rate through
blocking cell cycle in G2/M phase. It was also demonstratedthat nuclear Ca2+ plays a role on tumor growth in vivo and
it can alter the expression of genes involved in cell
proliferation. Moreover, modulation of nuclear Ca2+ signal-
ing was shown to be a potential target to treat cancer. How-
ever further studies are needed to better understand how
nuclear Ca2+ can be generated and how it regulates cell
proliferation and cell cycle progression. These findings
would have strong potential as therapeutic targets in dege-
nerative diseases or cancer.
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